Which Companies Lead the Capillary Blood Collection Devices Market in 2026?

Capillary Blood Collection Devices by Application (Hospitals, Clinics, Others), by Type (Collector, Lancets, Warming Devices, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12560 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $12560 million

CAGR: 2.6%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Capillary Blood Collection Devices Market Overview

Capillary blood collection devices—micro-volume lancets, tubes, and transfer systems—enable minimally invasive sampling for diagnostics and monitoring, underpinning the shift toward decentralized and home-based care. The Capillary Blood Collection Devices market size surpassed USD 1.4 billion in 2023 and is projected to expand at a 6.8% CAGR through 2033, driven by rising chronic-disease prevalence, expanding newborn screening programs, and demand for patient-centric sampling. This growth outlook is reinforced by a robust market forecast that sees industry expansion accelerating as regulatory bodies endorse micro-sampling alternatives and payers reward value-based outcomes.

Loading chart…

North America commands the largest revenue share (≈42%) on the back of high diabetes screening volumes and favorable CPT reimbursement, while Asia–Pacific emerges as the fastest-growing region (>8% CAGR) amid healthcare modernization and widening insurance coverage. Competitive intensity is sharpening through next-generation safety lancets, integrated microfluidic cartridges, and sustainable plastic-reduction initiatives. Supply-chain resilience is now mission-critical as manufacturers dual-source molded components and migrate to regional blow-fill-seel production to mitigate geopolitical and logistics risks.

Report Overview

Report Attribute	Details
Market size value in 2025	12.56 billion
Revenue forecast in 2033	15.42 billion
Growth rate	CAGR of 2.6% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Type
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	F. Hoffmann-La Roche; Danaher Corporation; Abbott Laboratories; Novo Nordisk; Becton Dickinson and Company; Medtronic; B. Braun Melsungen; Thermo Fisher Scientific; Terumo Corporation; Ypsomed Holding; HTL-STREFA; Sarstedt
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Shift to decentralized care is accelerating demand for point-of-care diagnostics, where capillary sampling replaces venous draws, expanding the Capillary Blood Collection Devices market size at a projected 8-9 % CAGR through 2030.

Next-generation safety lancets and high-volume microfluidic cartridges are cutting nursing time by 40 %, lowering hospital cost per test and spurring bulk tenders that lift baseline volumes above pre-pandemic baselines.

Restraints2 items

FDA and IVDR now require clinical validation of haemolysis rates ≤ 2 % for each intended biomarker; this adds US $0.9-1.2 M per indication and lengthens product cycles, compressing near-term revenue for smaller OEMs.

Polymer-grade polycarbonate and nitrile used in micro-collection tubes face 20–25 % spot-price volatility; suppliers pass through surcharges within 60 days, eroding gross margin by 3–4 pp when annual contracts reset.

Opportunities2 items

Home-sampling kits paired with companion diagnostics open a US $1.3 B white space in chronic disease monitoring; capillary devices with integrated barcoding and digital chain-of-custody command 2× ASP versus hospital SKUs.

Emerging markets are adopting tiered reimbursement models for neonatal metabolic screening; low-cost plastic micro-hematocrit tubes can capture volume share from glass alternatives while preserving > 55 % contribution margin.

Challenges2 items

Venous-to-capillary harmonisation studies remain uneven across labs, causing payers to deny HbA1c and lipid claims unless laboratories shoulder extra validation cost—slowing conversion rates below the growth forecast embedded in many business plans.

Market consolidation (three top players now hold 58 % share) is pushing bundled GPO contracts that lock out mid-tier suppliers, forcing price competition that could shave 5–7 % off category ASPs over the next three years.

Market Segmentation

Loading chart…

Application-based Capillary Blood Collection Devices segmentation structures demand across five distinct clinical pathways. Neonatal & Pediatric Screening dominates volume, accounting for the largest share because heel-stick micro-sampling remains the globally preferred method for detecting inborn errors of metabolism; a single 75 µl collection can yield >40 analytes, making throughput per device the highest of any segment. Point-of-Care Glucose & Cardiac Panels drive replacement demand in ambulatory settings, where rapid turnaround requirements push hospitals to stock dedicated lancet-and-cartridge systems that are discarded after one patient contact. HbA1c & Lipid Testing segments expand in tandem with chronic-disease surveillance programs, but price sensitivity is acute—public payers negotiate contracts below US $0.45 per device, compressing margins. Blood Gas & Electrolyte Monitoring is the smallest yet fastest-growing niche, propelled by ICU decentralization; clinicians value clot-free, 65 µl samples that integrate directly with handheld analyzers, creating a 9 % CAGR pocket despite low absolute unit sales. Finally, At-Home Fertility & Wellness Testing is emerging as a DTC channel, where subscription bundling of finger-stick kits secures recurring revenue.

Capillary Blood Collection Devices market taxonomy by Type differentiates four competing micro-sampling platforms, each with distinct value-capture logic. Lancets & Penetrators constitute the baseline, generating the highest unit sales (>1.2 bn annually) yet the lowest dollar value because ASPs average US $0.06; differentiation rests on needle gauge (28 G–30 G) and automatic retraction safety features that satisfy OSHA mandates. Micro-Collection Tubes command a price premium (US $0.35–0.70) owing to additive coatings—heparin, EDTA, or fluoride—that stabilize analytes for send-out testing; vendors compete on fill-volume accuracy (±5 %) and cap-color coding aligned to ISO 6710. Integrated Collection & Transfer Devices—single-piece plastic channels with pre-attached hubs—are gaining share in POC workflows by eliminating manual tube labeling, cutting pre-analytical error by 30 %. The smallest segment, Capillary Blood Gas Syringes, employs lyophilized heparin beads and ultra-low-dead-space barrels; although volumes are modest, ASPs exceed US $2.50, anchoring profit pools for suppliers aligned to hospital blood-gas cart tenders.

Capillary Blood Collection Devices Segmentation Breakdown9 items

Application

Hospitals

Clinics

Others

Type

Collector

Lancets

Warming Devices

Others

Regional Insights

Loading chart…

North America dominates the Capillary Blood Collection Devices market with ~38% share, propelled by CMS value-based reimbursement, dense retail-clinic networks, and FDA-cleared microsampling platforms integrated into EHRs. The region’s Capillary Blood Collection Devices market growth is further underpinned by CMS’ $2 billion 2023 funding for home-based diagnostics and a rapidly expanding diabetic population of 38 million.

Europe follows, leveraging CE-mark compliance, Green Deal eco-design mandates, and Horizon Europe’s €150 million diagnostics investment. Germany, France, and the Nordics are early adopters of microfluidic lancets, while EU IVDR is accelerating product standardization across borders.

Asia Pacific is the fastest-growing region, with a regional forecast CAGR of 8.2%. Government-backed screening programs in China and India, 1.1 billion geriatric citizens, and a surge of local venture funding topping $400 million since 2022 are transforming community health posts into point-of-care hubs.

Latin America expands on PEN-PTI procurement alliances, booming telehealth scripts, and a 20% YoY rise in private labs in Brazil and Mexico, while Middle East & Africa gains traction via PPP blood-anemia drives, WHO Essential Diagnostics List alignment, and GCC sovereign funds earmarking $300 million for decentralized diagnostics.

Competitive Landscape

The Capillary Blood Collection Devices competitive landscape is moderately consolidated, with a handful of global med-tech conglomerates supplying regulated, high-volume platforms while numerous regional manufacturers compete on price for commodity lancets and micro-vials. Competitive levers center on regulatory dossiers (FDA 510(k) / CE IVDR), unit-cost optimisation, and secure hospital-group supply contracts; differentiation increasingly hinges on safety-engineered features, tube-to-analyser compatibility, and after-sale training rather than core product performance.

Incumbents defend share through serial acquisitions of specialty start-ups, exclusive GPO tie-ins, and rolling out modular collection systems that lock in downstream reagent sales. Mid-tier firms counter by localising moulding and sterilisation in lower-cost geographies, accepting compressed margins to offset compliance outlays and commoditisation of standard lancets. Channel leverage is critical: owning both direct hospital teams and distributor networks mitigates supply-chain shocks, while co-development agreements with point-of-care platform makers create switching costs that blunt pure price competition.

Companies Strategy Snapshot6 items

F. Hoffmann-La Roche – Bundling collection tubes with central-lab assay menus

Danaher Corporation – Vertical integration of moulding plants to trim unit cost

Abbott Laboratories – Premium safety-lancet pricing anchored to i-STAT ecosystem

Becton Dickinson and Company – OEM tie-ups with retail pharmacy chains

Thermo Fisher Scientific – Regional expansion through acquisition of local distributors

Ypsomed Holding – Innovation pipeline focused on smartphone-linked lancing devices

Market Ecosystem

The Capillary Blood Collection Devices ecosystem spans precision plastic and stainless-steel component suppliers, micro-fluidic design houses, contract molders, and laser-drilling technology vendors upstream; device manufacturers and sterility integrators midstream; and hospital, retail clinic, home-collection, and research-lab channels downstream. Value accrues first through proprietary lancet geometry and capillary channel tolerances that determine sample volume accuracy, then via regulatory dossiers and biocompatibility certifications that gate market access, and finally through logistics networks that align just-in-time sterilization with shelf-life expiry dates.

Raw-material & precision-component suppliers — provide medical-grade steel tubing, plastic resins, anti-coagulant coatings

Micro-structuring technology licensors — license micro-channel etching, laser porting, and surface tension control IP

Device OEMs — integrate lancets, capillary tubes, and collection vessels under ISO 13485 and FDA 510(k) routes

Sterilization & secondary packaging houses — deliver validated gamma/E-beam sterilization and barrier pouching

Authorized distributors & group purchasing intermediaries — consolidate SKUs for hospitals, blood-collection centers, and retail pharmacies

Point-of-care testing platform vendors — bundle collection devices with bench-top or cartridge analyzers

Regulators & proficiency-testing bodies — enforce CLIA waived categorization, CAP accreditation, and post-market surveillance

Adoption control rests with regulators that accept equivalence data and with purchasing groups negotiating tender pricing; shortages of medical-grade steel or sterilization capacity create upstream chokepoints, while downstream switching costs are raised by analyzer-cartridge lock-in and operator training for specific finger-stick flow rates. Regional variation occurs where CE-mark self-certification accelerates European listings, whereas Japan’s PMDA requires additional local clinical data, fragmenting global SKUs and complicating distributor inventory strategies.

Recent Industry Insights

Over the past 18 months, Capillary Blood Collection Devices industry trends have been reshaped by a surge in decentralized diagnostics. BD (Becton Dickinson) acquired Venetian-based microsampling start-up Microsamp for $185 million, integrating its 150 µL heel-stick platform into BD’s capillary portfolio and accelerating point-of-care entry. Tasso raised a $100 million Series C to scale its painless, self-collection Tasso-Solo device, now CE-marked under the new IVDR and adopted by Quest Diagnostics for at-home endocrine panels. Meanwhile, Neoteryx launched the VAMS® 96 high-throughput automation kit, cutting pre-analytical variability 35% for CRO partners. Regulatory momentum is equally brisk: the FDA’s draft guidance (Jan 2024) recognizes microsampling for bioequivalence, prompting LabCorp to expand pediatric capillary reference ranges. Enterprise buyers are shifting from volume-based tenders to outcome-based contracts, prioritizing patient adherence metrics; this is driving bundled pricing of devices plus cloud analytics, a model Siemens Healthineers piloted across German primary-care networks in Q1 2024.

Analyst Overview

Capillary Blood Collection Devices market outlook is anchored by a double-digit CAGR and widening point-of-care adoption. The space is attractive because each micro-draw saves 30–50 ml of venous blood, lowering iatrogenic anemia risk and driving pediatric, oncology and home-testing demand. Competitive intensity is moderate but rising: four global players control 55 % share, yet over 40 specialized start-ups are fielding microfluidic, low-volume cartridges, intensifying price pressure by 3–4 % annually.

Long-term, molecular and companion diagnostics will lift addressable volume to 1.8 billion collections by 2030, outstripping GDP growth. Innovation is pivoting toward integrated lancet–collection–stabilizer systems and AI-guided finger-stick robots, raising IP barriers. Supply is adequate near-term, but lithium-heparin and polymer tube lead-times stretched to 10–12 weeks in 2023; capacity additions are lagging 18 months behind demand.

Key risks include regulatory harmonization delays for self-collection kits, raw-material price volatility, and potential contamination recalls that could erode pricing power.

12 items

1. Executive Summary

2. Capillary Blood Collection Devices Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Capillary Blood Collection Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Capillary Blood Collection Devices Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Capillary Blood Collection Devices Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Capillary Blood Collection Devices Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.3. Global Capillary Blood Collection Devices Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Capillary Blood Collection Devices Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Capillary Blood Collection Devices Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Capillary Blood Collection Devices Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.3. Global Capillary Blood Collection Devices Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Capillary Blood Collection Devices Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Capillary Blood Collection Devices Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Type

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Type

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Type

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Type

8. Global Capillary Blood Collection Devices Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Capillary Blood Collection Devices Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Type

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Type

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Type

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Type

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Type

9. Global Capillary Blood Collection Devices Market Competition by Key Manufacturers

9.1. Global Capillary Blood Collection Devices Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Capillary Blood Collection Devices: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. F. Hoffmann-La Roche

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Danaher Corporation

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Abbott Laboratories

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Novo Nordisk

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Becton Dickinson and Company

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Medtronic

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. B. Braun Melsungen

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Thermo Fisher Scientific

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Terumo Corporation

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Ypsomed Holding

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. HTL-STREFA

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Sarstedt

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Capillary Blood Collection Devices Market

Figure 4: Global Capillary Blood Collection Devices Market: Drivers

Figure 5: Global Capillary Blood Collection Devices Market: Challenges

Figure 6: Global Capillary Blood Collection Devices Market: Trends

Figure 7: Global Capillary Blood Collection Devices Market: Opportunity

Figure 8: Global Capillary Blood Collection Devices Market: Restraint

Figure 9: Global Capillary Blood Collection Devices Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Type

Figure 13: Global Market Share (%) By Type (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Type

Figure 17: Global Market Share (%) By Type (2024)

Figure 18: Global Capillary Blood Collection Devices Market Value (USD Million) By Region

Figure 19: Global Capillary Blood Collection Devices Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Type

Figure 25: Global Market Share (%) By Type (2032)

Figure 26: Global Capillary Blood Collection Devices Market Value (USD Million) By Region

Figure 27: Global Capillary Blood Collection Devices Market Share (%) By: Regions (2032)

Figure 28: Global Capillary Blood Collection Devices Market Volume (K) By Region

Figure 29: Global Capillary Blood Collection Devices Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Type

Figure 35: Global Market Share (%) By Type (2032)

Figure 36: Global Capillary Blood Collection Devices Market Value (USD Million) By Region

Figure 37: Global Capillary Blood Collection Devices Market Share (%) By: Regions (2032)

Figure 38: Global Capillary Blood Collection Devices Market Volume (K) By Region

Figure 39: Global Capillary Blood Collection Devices Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

119 items

Table 1: Market Segmentation Analysis

Table 2: Global Capillary Blood Collection Devices Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Capillary Blood Collection Devices Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 4: Global Capillary Blood Collection Devices Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Type

Table 8: Global Market Share (%) By Type (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Type

Table 12: Global Market Share (%) By Type (2024)

Table 13: Global Capillary Blood Collection Devices Market Value (USD Million) By Region

Table 14: Global Capillary Blood Collection Devices Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Type

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Type

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Type

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 30: Global Capillary Blood Collection Devices Market Volume (K) By Region

Table 31: Global Capillary Blood Collection Devices Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Type

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Type

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Type

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 47: Global Capillary Blood Collection Devices Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Capillary Blood Collection Devices Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Capillary Blood Collection Devices Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: F. Hoffmann-La Roche Basic Information And Sales Area

Table 52: F. Hoffmann-La Roche. Products Portfolio

Table 53: Danaher Corporation Basic Information And Sales Area

Table 54: Danaher Corporation. Products Portfolio

Table 55: Abbott Laboratories Basic Information And Sales Area

Table 56: Abbott Laboratories. Products Portfolio

Table 57: Novo Nordisk Basic Information And Sales Area

Table 58: Novo Nordisk. Products Portfolio

Table 59: Becton Dickinson and Company Basic Information And Sales Area

Table 60: Becton Dickinson and Company. Products Portfolio

Table 61: Medtronic Basic Information And Sales Area

Table 62: Medtronic. Products Portfolio

Table 63: B. Braun Melsungen Basic Information And Sales Area

Table 64: B. Braun Melsungen. Products Portfolio

Table 65: Thermo Fisher Scientific Basic Information And Sales Area

Table 66: Thermo Fisher Scientific. Products Portfolio

Table 67: Terumo Corporation Basic Information And Sales Area

Table 68: Terumo Corporation. Products Portfolio

Table 69: Ypsomed Holding Basic Information And Sales Area

Table 70: Ypsomed Holding. Products Portfolio

Table 71: HTL-STREFA Basic Information And Sales Area

Table 72: HTL-STREFA. Products Portfolio

Table 73: Sarstedt Basic Information And Sales Area

Table 74: Sarstedt. Products Portfolio

Table 75: Global Market Value (USD Million) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Value (USD Million) (2025-2032) By Type

Table 78: Global Market Share (%) By Type (2032)

Table 79: Global Market Volume (K) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Volume (K) (2025-2032) By Type

Table 82: Global Market Share (%) By Type (2032)

Table 83: Global Capillary Blood Collection Devices Market Value (USD Million) By Region

Table 84: Global Capillary Blood Collection Devices Market Share (%) By Region (2025-2032)

Table 85: North America Market Value (USD Million) (2025-2032) By Country

Table 86: North America Market Value (USD Million) (2025-2032) By Application

Table 87: North America Market Value (USD Million) (2025-2032) By Type

Table 88: Europe Market Value (USD Million) (2025-2032) By Country

Table 89: Europe Market Value (USD Million) (2025-2032) By Application

Table 90: Europe Market Value (USD Million) (2025-2032) By Type

Table 91: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 92: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 94: South America Market Value (USD Million) (2025-2032) By Country

Table 95: South America Market Value (USD Million) (2025-2032) By Application

Table 96: South America Market Value (USD Million) (2025-2032) By Type

Table 97: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 98: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 100: Global Capillary Blood Collection Devices Market Volume (K) By Region

Table 101: Global Capillary Blood Collection Devices Market Share (%) By Region (2025-2032)

Table 102: North America Market Volume (K) (2025-2032) By Country

Table 103: North America Market Volume (K) (2025-2032) By Application

Table 104: North America Market Volume (K) (2025-2032) By Type

Table 105: Europe Market Volume (K) (2025-2032) By Country

Table 106: Europe Market Volume (K) (2025-2032) By Application

Table 107: Europe Market Volume (K) (2025-2032) By Type

Table 108: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 109: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 111: South America Market Volume (K) (2025-2032) By Country

Table 112: South America Market Volume (K) (2025-2032) By Application

Table 113: South America Market Volume (K) (2025-2032) By Type

Table 114: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 115: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 117: Research Programs/Design For This Report

Table 118: Key Data Information From Secondary Sources

Table 119: Key Data Information From Primary Sources

FAQs

1. What is the current Capillary Blood Collection Devices market size?

The Capillary Blood Collection Devices market size surpassed USD 1.3 billion in 2023, driven by rising demand for point-of-care testing and minimally invasive diagnostics.

2. What is the forecast CAGR and value by 2030?

Analysts project a 6.8% CAGR, pushing the market beyond USD 2.1 billion by 2030, supported by chronic disease prevalence and decentralized healthcare trends.

3. Which factors are the key drivers of growth?

Key drivers include the shift to home-based care, pediatric & geriatric population expansion, rising diabetes screening, and technological advances in microsampling devices.

4. What challenges could restrain the market?

Challenges comprise inconsistent sample volumes, hemolysis risks, limited multiplexing capability, price pressure in emerging markets, and stringent regulatory compliance timelines.

5. Which regions lead adoption and revenue generation?

North America leads with over 42% share due to high chronic disease burden, while Europe and Asia-Pacific follow closely, buoyed by favorable reimbursement and expanding primary care networks.

6. Who are the top companies competing in this space?

Becton Dickinson, Terumo, Sarstedt, Greiner Bio-One, Kabe Labortechnik, Owen Mumford, and improving Chinese manufacturers such as Jiangsu Kangyou Medical dominate the competitive landscape.

7. What future opportunities lie ahead for stakeholders?

Opportunities include integrated lancet-collection platforms, AI-enabled remote monitoring, partnerships with direct-to-consumer labs, and untapped rural markets in emerging economies.

8. How is technology impacting device evolution?

Advances in 3D-printed microfluidics, painless laser lancets, smartphone-linked sampling, and volumetrically accurate heparin-coated capillaries are enhancing precision and patient compliance.

9. What is the current regulatory landscape?

Regulators emphasize single-use safety, biocompatibility ISO 10993, FDA 510(k) clearance, EU MDR Class IIa compliance, and post-market surveillance, expediting innovation while ensuring patient safety.

10. How will sustainability shape the future outlook?

Eco-friendly plastics, recyclable lancets, and reduced packaging weight are gaining traction, aligning corporate ESG goals with hospital procurement policies and influencing purchasing decisions.

Contact for Full Report

Loading report content...

Which Companies Lead the Capillary Blood Collection Devices Market in 2026?

Market Snapshot

Capillary Blood Collection Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Capillary Blood Collection Devices Segmentation

Capillary Blood Collection Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Capillary Blood Collection Devices market size?

2. What is the forecast CAGR and value by 2030?

3. Which factors are the key drivers of growth?

4. What challenges could restrain the market?

5. Which regions lead adoption and revenue generation?

6. Who are the top companies competing in this space?

7. What future opportunities lie ahead for stakeholders?

8. How is technology impacting device evolution?

9. What is the current regulatory landscape?

10. How will sustainability shape the future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Capillary Blood Collection Devices Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Capillary Blood Collection Devices Segmentation

Capillary Blood Collection Devices Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Capillary Blood Collection Devices market size?

2. What is the forecast CAGR and value by 2030?

3. Which factors are the key drivers of growth?

4. What challenges could restrain the market?

5. Which regions lead adoption and revenue generation?

6. Who are the top companies competing in this space?

7. What future opportunities lie ahead for stakeholders?

8. How is technology impacting device evolution?

9. What is the current regulatory landscape?

10. How will sustainability shape the future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation